Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor
PTC
‐209 in acute myeloid leukemia: Implications for leukemia therapy
2014 ◽
Vol 15
(4)
◽
pp. 166-173
◽
Keyword(s):